Good one from the swamp:
farrell90 Member Level
Good one from the swamp:
farrell90 Member Level Saturday, 09/09/17 04:12:10 PM
Re: farrell90 post# 196176
Post #
196229
of 196258 Go
Presentation has much more emphasis on financial potential of pharmaceuticals than past presentations. After re reading added more points
IPIX sounds very confident in the science and potential of their drugs.
Financial talking points below found in presentation:
1. Near-Term Catalysts by Year-End—trial completion, results reporting;
collaboration/partnership opportunities
2. All three Clinical Assets,Brilacidin,Prurisol,Kevetrin, targeting Multi-Billion Markets in numerous
therapeutic areas, across multiple clinical indications.
3. Multi-billion opportunities with Prurisol{> 9 billion market, Kevetrin >7 billion dollar market, Brilacidin ABSSSI, OM, IBD multibillion dollar markets.
4. All 3 primary drug candidates have the potential to help millions of patients worldwide.
5.There is big money again in saving Humanity with antibiotics
6.Strategic focus:Capture ROI through partnerships
7.Leverage 2017 milestones to support partnering opportunities
8.Multiple CDAs signed ongoing interactions with Big Pharma and Global Rx companies
9.Continue to build value by addressing areas of unmet medical needs for the benefit of patients and shareholders
10. Anchor each drug candidate in additional trials to further provide favorable return on investment
Go IPIX!!!
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Biotech Investment: Between a Rock and a Hard Place The U.S. Department of the Treasury just threw a curveball at the biotechnology sector with its proposal to shore up the Comprehensive Outbound Investment National Security (COINS) Act. This ain't just another set of lines on a folded napkin; the new rules would put a chokehold on American investments flowing into...
Continue Reading
Here we go with an unexpected twist in the phone accessory game. CASEKOO decided it's time to mix things up this Halloween with something as peculiar as it is intriguing: limited-edition Spooky Season Commemorative Postcards. A Spooky Strategy to Celebrate Ten Years Get this, folks—CASEKOO's looking to mark a decade in the business with more than just confetti and a...
Continue Reading
Who knew that mini bikes could pack such a punch? Enter the M3 from the folks at FRP Moto. This isn't just another two-wheeler for the kiddie circuit. Nope, this one's got the juice to make even seasoned riders do a double take. We're talking electric power, a top speed of 55 mph, and some snazzy wheelie modes. A Look Under the Hood Get this – the M3 isn’t your...
Continue Reading
A New Way to Nurture Patient Relationships This isn't just another cookie-cutter patient care program rolling out—it’s a genuine shake-up in the way doctors connect with their patients. Rishika Kaundal, MD, a dedicated family medicine physician, is pioneering change in Midlothian, Virginia with her Hybrid Choice™ concierge program. This isn't a fluff piece; it's a...
Continue Reading
Mobile Drama: A Quick Escape with Reel Drops In this fast-moving world, where time feels as elusive as a daydream, Eightpoint is shaking up mobile entertainment with its brand-new app, Reel Drops. Based out of George Town, Cayman Islands, this app aims to give viewers a shot at swift, captivating storytelling without the marathon commitment of a binge-watch session. A New...
Continue Reading
Tackling Aberdeen's New Playbook Aberdeen Multi-Market Income Fund (NYSE: MMT) is pulling the trigger on a 1-for-4 reverse stock split come November 9, 2026. This isn't your average headline-grabbing move but one that could shake up how MMT trades. It’s a classic case of tidying up shop, aiming to bolster the share price and streamline share trading. No Change in Fund...
Continue Reading
A Look Under the Hood of Concrete Admixtures It's a concrete jungle out there, folks—literally. The once overlooked market of concrete admixtures is gearing up for quite the makeover, projected to hit USD 35.87 billion by 2035. For those of you tuning in, we're talking about chemicals that mix into your average concrete to change its properties. And, believe it or not,...
Continue Reading
Rollin' Down the Road of Excellence In the world of healthcare logistics, Medline's MedTrans team isn't just steering trucks—they're steering safety culture and supply chain efficiency. This October, they wrapped up their fourth annual National Truck Rodeo in Mundelein, Illinois. And let me tell you, it was more than just a fancy event. It was about celebrating the real...
Continue Reading
Unexpected Surge in Northern Virginia's Inventory Walking around Fairfax these days, you might feel like you're in a time warp, especially if you're tracking the housing market. See, while the rest of the country's housing market groans under sluggish sales and creeping prices, Northern Virginia's doing a dance of its own. Inventory's ballooning faster than a parade...
Continue Reading
Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...
Continue Reading
Top 5 Most Recently Viewed Articles
Trouble Brewing for Papa John's Investors Rolling the dice in the stock market sometimes feels like playing the lottery, doesn't it? This time around, it's Papa John's (NASDAQ: PZZA) serving up a slice of turmoil for its investors. The pizza chain's got itself tangled in a class-action lawsuit, and it's the shareholders who're left with a bitter taste. Investors Cry Foul...
Continue Reading
Pliant Therapeutics Elicits Attention with New Trial Findings Pliant Therapeutics, Inc. (NASDAQ: PLRX) has been generating buzz following encouraging trial results for its innovative cancer treatment, PLN-101095. This comes at a time when the stock has faced a notable downturn. PLRX Stock Overview Currently, PLRX stock exhibits some weakness in the market. Investors are...
Continue Reading
Thomas the Tank Engine's 80th Birthday Celebration is Here! All Aboard! Thomas the Tank Engine, the beloved blue engine known to all, is returning for an extraordinary event to mark his 80th Birthday. The Day Out With Thomas: The Party Tour is set to bring a delightful experience to Greenfield Village, home of The Henry Ford. A One-of-a-Kind Experience Awaits Join us in...
Continue Reading
AlphaTheta Launches New Apparel Collection The new collection of seasonal apparel and everyday essentials is inspired by the universal language of music. AlphaTheta is thrilled to announce its first apparel collection, aptly named "One Through Music," which seamlessly blends the joy of music with stylish and functional everyday wear. This exciting launch aims to enhance...
Continue Reading
Understanding HDFC Bank Ltd’s Short Interest Trends HDFC Bank Ltd (NYSE:HDB) has seen an uptick in its short interest, rising by 9.68% since its last report. Presently, there are approximately 17.40 million shares sold short, accounting for 0.34% of the total shares available for trading. With the current trading volume, it takes around 5.23 days for traders to cover...
Continue Reading